Mixed messages as Zverev supposedly allowed to inject insulin on court according to tournament spokesperson

Fans have reacted to the discussion surrounding Alexander Zverev and on-court insulin injections.

The German player has had type 1 diabetes since he was three years old. Zverev has become embroiled in controversy due to the authorization he has to inject insulin during ATP tournaments, but not during the 2023 French Open.

According to the former world No. 2, the Roland Garros organization has stated that it "looks weird," sparking mixed opinions among fans.

Zverev will play tomorrow in the quarterfinals of the French Open against Argentine Tomas Etcheverry. The winner will face either Holger Rune or Casper Ruud.

Place comments



More comments

You are currently seeing only the comments you are notified about, if you want to see all comments from this post, click the button below.

Show all comments